Added to YB: 2026-04-24
Pitch date: 2026-04-22
MMED [neutral]
MiniMed Group, Inc.
-6.82%
current return
Author Info
Company Info
MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes.
Market Cap
$3.5B
Pitch Price
$13.20
Price Target
32.05 (+161%)
Dividend
N/A
EV/EBITDA
-219.07
P/E
-9.53
EV/Sales
1.13
Sector
Health Care Equipment and Supplies
Category
special_situation
Corporate dark arts: one bizarre case study, one false signal, and three setups to watch - $MMED
MMED (quick overview): Recent MDT spin at $20, now mid-teens, 90% still owned by MDT. Execs got PSUs vesting at $32.05 by Mar 2027 (~60% upside from IPO, >100% from current). FDA approved next-gen insulin pump post-IPO. Thin float + MDT exit in ~6mo could create volatility. Rare combo of aggressive price target incentive + controlling shareholder disposal.
Read full article (2 min)